Nemes Rush Group LLC

Source: SEC Form 13F · as of Mar 2026

Nemes Rush Group LLC holds 55 biotech & pharma companies tracked by BioSniper, totaling $70.1M in value as of Mar 2026 (SEC Form 13F).

Companies held

55

Total value held

$70.1M

CompanySharesValue
JNJJOHNSON & JOHNSON89,225$21.8M
MRKMerck & Co., Inc.170,964$20.6M
LLYELI LILLY & Co15,197$14.0M
GILDGILEAD SCIENCES, INC.26,940$3.8M
ABBVAbbVie Inc.16,011$3.5M
VRTXVERTEX PHARMACEUTICALS INC / MA5,605$2.5M
BMYBRISTOL MYERS SQUIBB CO25,698$1.6M
PMPhilip Morris International Inc3,752$620K
VKTXViking Therapeutics, Inc.5,468$417K
ABTABBOTT LABORATORIES2,780$285K
MEDPMedpace Holdings Inc.571$274K
PFEPFIZER INC9,049$254K
GMOptec International, Inc.1,636$122K
TGTXTG THERAPEUTICS, INC.2,019$67K
IQVIQVIA Holdings Inc.373$64K
AMGNAMGEN INC146$51K
ACADACADIA PHARMACEUTICALS INC2,000$45K
SLSSELLAS Life Sciences Group, Inc.10,000$42K
UNHUnitedHealth Group Incorporated Common Stock (DE)140$38K
GEHCGE HealthCare Technologies Inc.257$18K
MCKMcKesson Corporation16$14K
CRMDCorMedix Inc.2,000$14K
DNLIDenali Therapeutics Inc.700$13K
NVSNovartis AG80$12K
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)188$10K
ZTSZoetis Inc.69$8K
REGNREGENERON PHARMACEUTICALS, INC.8$6K
CORCencora Inc.15$5K
ELVElevance Health Inc.14$4K
NVONovo Nordisk A/S106$4K
VTRSViatris Inc261$4K
GMEDGlobus Medical Inc.40$3K
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)169$3K
IDXXIDEXX LABORATORIES INC /DE4$2K
ARGXARGENX SE3$2K
TEVATeva Pharmaceutical Industries Limited72$2K
NEOGNEOGEN CORP214$2K
ALNYALNYLAM PHARMACEUTICALS, INC.5$2K
DGXQuest Diagnostics Incorporated7$1K
ONCBeOne Medicines Ltd.4$1K
RPRXRoyalty Pharma plc20$959
OGNOrganon & Co.148$887
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.5$863
CAHCardinal Health Inc.4$845
AVNSAvanos Medical Inc.51$715
BAXBaxter International Inc.40$667
INSMINSMED Inc2$327
DVADaVita Inc.2$307
ELANElanco Animal Health Inc10$239
JAZZJazz Pharmaceuticals plc1$189
INCYIncyte Corp.2$188
BIIBBIOGEN INC.1$183
EDITEditas Medicine, Inc.50$124
GNPXGenprex, Inc.5$9
AKBAAkebia Therapeutics, Inc.2$3

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Nemes Rush Group LLC — Biotech 13F Holdings & Portfolio | BioSniper